Body Composition in Inflammatory Bowel Disease.
Study Design
- 研究タイプ
- Review
- 対象集団
- Clinical remission
- 介入
- Body Composition in Inflammatory Bowel Disease. None
- 比較対照
- None
- 主要アウトカム
- inflammation markers
- 効果の方向
- Positive
- バイアスリスク
- Unclear
Abstract
Inflammatory bowel disease (IBD) is associated with body composition changes, which are associated with clinical prognosis, response to therapy, and quality of life in IBD patients. Therefore, it is critical to review the body composition distribution in IBD, summarize the potential factors affecting body composition distribution, and take steps to improve the body composition distribution of IBD patients as early as possible. In the current review, we searched PubMed via keywords 'inflammatory bowel disease', or 'IBD', or 'Crohn's disease', or 'CD', or 'ulcerative colitis', or 'UC', and 'body composition'. Malnutrition and sarcopenia are common in IBD patients and are associated with the clinical course, prognosis, and need for surgery. Disease activity, reduced nutrition intake, vitamin D deficiency, and intestinal dysbiosis are factors contributing to changed body composition. Early use of biological agents to induce remission is critical to improving body composition distribution in IBD patients, supplementation of vitamin D is also important, and moderate physical activity is recommended in IBD patients with clinical remission.
要約
Early use of biological agents to induce remission is critical to improving body composition distribution in IBD patients, supplementation of vitamin D is also important, and moderate physical activity is recommended in IBD patients with clinical remission.
Full Text
Used In Evidence Reviews
Similar Papers
Journal of inflammation research · 2014
Vitamin D and inflammatory diseases.
Gastroenterology · 2017
Diet as a Trigger or Therapy for Inflammatory Bowel Diseases.
The journal of headache and pain · 2020
Gut-brain Axis and migraine headache: a comprehensive review.
Joint bone spine · 2010
Vitamin D and inflammation.
The Australian and New Zealand journal of psychiatry · 2017
A double-blind, randomized, placebo-controlled trial of Lactobacillus helveticus and Bifidobacterium longum for the symptoms of depression.
World journal of gastroenterology · 2016